Human CD4+CD3- innate-like T cells provide a source of TNF and lymphotoxin-ap and are elevated in rheumatoid arthritis

Journal of Immunology

Volumn 191, Issue 9, 2013, Pages 4611-4618

  Bekiaris, Vasileios ^a   Šedý, John R ^a   Rossetti, Maura ^a   Spreafico, Roberto ^a   Sharma, Shilpi ^a   Rhode Kurnow, Antje ^a   Ware, Brian C ^a   Huang, Nini ^a   Macauley, Matthew G ^a   Norris, Paula S ^a   Albani, Salvatore ^a   Ware, Carl F ^a  

^a BURNHAM INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR6; INTERLEUKIN 17; INTERLEUKIN 7 RECEPTOR; LYMPHOTOXIN ALPHA BETA; T LYMPHOCYTE RECEPTOR; TUMOR NECROSIS FACTOR; CCR6 PROTEIN, HUMAN; CD3 ANTIGEN; HOMEODOMAIN PROTEIN; INTERLEUKIN 7; INTERLEUKIN 7 RECEPTOR ALPHA; RAG-1 PROTEIN;

ADULT; AGED; ANIMAL CELL; ARTICLE; CD4+ CD3- T LYMPHOCYTE; CELL LINEAGE; CELL SURFACE; CELL SURVIVAL; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; EMBRYO; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPHOCYTE SUBPOPULATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN PROTEIN INTERACTION; RHEUMATOID ARTHRITIS; T LYMPHOCYTE; UPREGULATION; ANIMAL; CD4+ T LYMPHOCYTE; CELL LINE; GENETICS; HEK293 CELL LINE; IMMUNOLOGY; INFLAMMATION; KNOCKOUT MOUSE; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; METABOLISM; MIDDLE AGED;

ADULT; AGED; ANIMALS; ANTIGENS, CD3; ARTHRITIS, RHEUMATOID; CD4-POSITIVE T-LYMPHOCYTES; CELL LINE; FEMALE; HEK293 CELLS; HOMEODOMAIN PROTEINS; HUMANS; INFLAMMATION; INTERLEUKIN-7; INTERLEUKIN-7 RECEPTOR ALPHA SUBUNIT; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; LYMPHOTOXIN ALPHA1, BETA2 HETEROTRIMER; MALE; MICE; MICE, KNOCKOUT; MIDDLE AGED; RECEPTORS, CCR6; TUMOR NECROSIS FACTORS;

EID: 84886029298     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1301672     Document Type: Article

References (50)

1. Eberl, G., S. Marmon, M. J. Sunshine, P. D. Rennert, Y. Choi, and D. R. Littman. 2004. An essential function for the nuclear receptor RORgamma(t) in the generation of fetal lymphoid tissue inducer cells. Nat. Immunol. 5: 64-73.
2. Cupedo, T., N. K. Crellin, N. Papazian, E. J. Rombouts, K. Weijer, J. L. Grogan, W. E. Fibbe, J. J. Cornelissen, and H. Spits. 2009. Human fetal lymphoid tissueinducer cells are interleukin 17-producing precursors to RORC+ CD127+ natural killer-like cells. Nat. Immunol. 10: 66-74.
3. - LTbeta+ cells that can differentiate to APC, NK cells, and follicular cells but not T or B cells. Immunity 7: 493-504.
4. - cells induce Peyer's patch development: role of alpha4beta1 integrin activation by CXCR5. Immunity 17: 363-373.
5. Withers, D. R., M. Y. Kim, V. Bekiaris, S. W. Rossi, W. E. Jenkinson, F. Gaspal F. McConnell, J. H. Caamano, G. Anderson, and P. J. Lane. 2007. The role of lymphoid tissue inducer cells in splenic white pulp development. Eur. J. Immunol. 37: 3240-3245.
6. Rossi, S. W., M. Y. Kim, A. Leibbrandt, S. M. Parnell, W. E. Jenkinson, S. H. Glanville, F. M. McConnell, H. S. Scott, J. M. Penninger, E. J. Jenkinson, et al 2007. RANK signals from CD4(+)3(-) inducer cells regulate development of Aire-expressing epithelial cells in the thymic medulla. J. Exp. Med. 204: 1267-1272.
7. Bekiaris, V., F. Gaspal, F. M. McConnell, M. Y. Kim, D. R. Withers, C. Sweet, G. Anderson, and P. J. Lane. 2009. NK cells protect secondary lymphoid tissue from cytomegalovirus via a CD30-dependent mechanism. Eur. J. Immunol. 39: 2800-2808.
8. - CD56-OX40Lhigh cells express IL-22 and display an LTi phenotype in human secondary lymphoid tissues. Eur. J. Immunol. 41: 1563-1572.
9. Kim, M. Y., F. M. Gaspal, H. E. Wiggett, F. M. McConnell, A. Gulbranson Judge, C. Raykundalia, L. S. Walker, M. D. Goodall, and P. J. Lane. 2003. CD4 (+)CD3(-) accessory cells costimulate primed CD4 T cells through OX40 and CD30 at sites where T cells collaborate with B cells. Immunity 18: 643-654.
10. Withers, D. R., F. M. Gaspal, E. C. Mackley, C. L. Marriott, E. A. Ross, G. E. Desanti, N. A. Roberts, A. J. White, A. Flores-Langarica, F. M. McConnell, et al 2012. Cutting edge: lymphoid tissue inducer cells maintain memory CD4 T cells within secondary lymphoid tissue. J. Immunol. 189: 2094-2098.
11. Vonarbourg, C., A. Mortha, V. L. Bui, P. P. Hernandez, E. A. Kiss, T. Hoyler, M. Flach, B. Bengsch, R. Thimme, C. Hölscher, et al 2010. Regulated expression of nuclear receptor RORγt confers distinct functional fates to NK cell receptor-expressing RORγt(+) innate lymphocytes. Immunity 33: 736-751.
12. Sonnenberg, G. F., L. A. Monticelli, T. Alenghat, T. C. Fung, N. A. Hutnick, J. Kunisawa, N. Shibata, S. Grunberg, R. Sinha, A. M. Zahm, et al. 2012. Innate lymphoid cells promote anatomical containment of lymphoid-resident commensal bacteria. Science 336: 1321-1325.
13. Lee, J. S., M. Cella, K. G. McDonald, C. Garlanda, G. D. Kennedy, M. Nukaya, A. Mantovani, R. Kopan, C. A. Bradfield, R. D. Newberry, and M. Colonna. 2012. AHR drives the development of gut ILC22 cells and postnatal lymphoid tissues via pathways dependent on and independent of Notch. Nat. Immunol. 13: 144-151.
14. Kiss, E. A., C. Vonarbourg, S. Kopfmann, E. Hobeika, D. Finke, C. Esser, and A. Diefenbach. 2011. Natural aryl hydrocarbon receptor ligands control organogenesis of intestinal lymphoid follicles. Science 334: 1561-1565.
15. Satoh-Takayama, N., C. A. Vosshenrich, S. Lesjean-Pottier, S. Sawa, M. Lochner, F. Rattis, J. J. Mention, K. Thiam, N. Cerf-Bensussan, O. Mandelboim, et al 2008. Microbial flora drives interleukin 22 production in intestinal NKp46+ cells that provide innate mucosal immune defense. Immunity 29: 958-970.
16. Kim, M. Y., S. Rossi, D. Withers, F. McConnell, K. M. Toellner, F. Gaspal, E. Jenkinson, G. Anderson, and P. J. Lane. 2008. Heterogeneity of lymphoid tissue inducer cell populations present in embryonic and adult mouse lymphoid tissues. Immunology 124: 166-174.
17. Rooney, I. A., K. D. Butrovich, A. A. Glass, S. Borboroglu, C. A. Benedict, J. C. Whitbeck, G. H. Cohen, R. J. Eisenberg, and C. F. Ware. 2000. The lymphotoxin-beta receptor is necessary and sufficient for LIGHT-mediated apoptosis of tumor cells. J. Biol. Chem. 275: 14307-14315.
18. Yokota, Y., A. Mansouri, S. Mori, S. Sugawara, S. Adachi, S. Nishikawa, and P. Gruss. 1999. Development of peripheral lymphoid organs and natural killer cells depends on the helix-loop-helix inhibitor Id2. Nature 397: 702-706.
19. Spits, H., and J. P. Di Santo. 2011. The expanding family of innate lymphoid cells: regulators and effectors of immunity and tissue remodeling. Nat. Immunol. 12: 21-27.
20. Feldmann, M., and R. N. Maini. 2010. Anti-TNF therapy, from rationale to standard of care: what lessons has it taught us? J. Immunol. 185: 791-794.
21. Firestein, G. S. 2004. The T cell cometh: interplay between adaptive immunity and cytokine networks in rheumatoid arthritis. J. Clin. Invest. 114: 471-474.
22. Haas, J. D., S. Ravens, S. Düber, I. Sandrock, L. Oberdörfer, E. Kashani V. Chennupati, L. Föhse, R. Naumann, S. Weiss, et al. 2012. Development of interleukin-17-producing γδ T cells is restricted to a functional embryonic wave. Immunity 37: 48-59.
23. Tumanov, A. V., E. P. Koroleva, X. Guo, Y. Wang, A. Kruglov, S. Nedospasov, and Y. X. Fu. 2011. Lymphotoxin controls the IL-22 protection pathway in gut innate lymphoid cells during mucosal pathogen challenge. Cell Host Microbe 10: 44-53.
24. Aggarwal, B. B. 2003. Signalling pathways of the TNF superfamily: a doubleedged sword. Nat. Rev. Immunol. 3: 745-756.
25. Hoyler, T., C. S. Klose, A. Souabni, A. Turqueti-Neves, D. Pfeifer, E. L. Rawlins, D. Voehringer, M. Busslinger, and A. Diefenbach. 2012. The transcription factor GATA-3 controls cell fate and maintenance of type 2 innate lymphoid cells. Immunity 37: 634-648.
26. Moro, K., T. Yamada, M. Tanabe, T. Takeuchi, T. Ikawa, H. Kawamoto, J. Furusawa, M. Ohtani, H. Fujii, and S. Koyasu. 2010. Innate production of T(H)2 cytokines by adipose tissue-associated c-Kit(+)Sca-1(+) lymphoid cells. Nature 463: 540-544.
27. Meier, D., C. Bornmann, S. Chappaz, S. Schmutz, L. A. Otten, R. Ceredig H. Acha-Orbea, and D. Finke. 2007. Ectopic lymphoid-organ development occurs through interleukin 7-mediated enhanced survival of lymphoid-tissueinducer cells. Immunity 26: 643-654.
28. -/mice. J. Immunol. 157: 2366-2373.
29. Michel, M. L., D. J. Pang, S. F. Haque, A. J. Potocnik, D. J. Pennington, and A. C. Hayday. 2012. Interleukin 7 (IL-7) selectively promotes mouse and human IL-17-producing γδ cells. Proc. Natl. Acad. Sci. USA 109: 17549-17554.
30. Yoshida, H., A. Naito, J. Inoue, M. Satoh, S. M. Santee-Cooper, C. F. Ware, A. Togawa, S. Nishikawa, and S. Nishikawa. 2002. Different cytokines induce surface lymphotoxin-alphabeta on IL-7 receptor-alpha cells that differentially engender lymph nodes and Peyer's patches. Immunity 17: 823-833.
31. Sawa, S., M. Cherrier, M. Lochner, N. Satoh-Takayama, H. J. Fehling, F. Langa J. P. Di Santo, and G. Eberl. 2010. Lineage relationship analysis of RORgammat+ innate lymphoid cells. Science 330: 665-669.
32. Cook, D. N., D. M. Prosser, R. Forster, J. Zhang, N. A. Kuklin S. J. Abbondanzo, X. D. Niu, S. C. Chen, D. J. Manfra, M. T. Wiekowski, et al. 2000. CCR6 mediates dendritic cell localization, lymphocyte homeostasis, and immune responses in mucosal tissue. Immunity 12: 495-503.
33. Mabuchi, T., T. P. Singh, T. Takekoshi, G. F. Jia, X. Wu, M. C. Kao, I. Weiss, J. M. Farber, and S. T. Hwang. 2013. CCR6 is required for epidermal trafficking of γδ-T cells in an IL-23-induced model of psoriasiform dermatitis. J. Invest. Dermatol. 133: 164-171.
34. Varona, R., R. Villares, L. Carramolino, I. Goya, A. Zaballos, J. Gutiérrez, M. Torres, C. Martínez-A, and G. Márquez. 2001. CCR6-deficient mice have impaired leukocyte homeostasis and altered contact hypersensitivity and delayed-type hypersensitivity responses. J. Clin. Invest. 107: R37-R45.
35. Bouskra, D., C. Brézillon, M. Bérard, C. Werts, R. Varona, I. G. Boneca, and G. Eberl. 2008. Lymphoid tissue genesis induced by commensals through NOD1 regulates intestinal homeostasis. Nature 456: 507-510.
36. Banks, T. A., B. T. Rouse, M. K. Kerley, P. J. Blair, V. L. Godfrey, N. A. Kuklin D. M. Bouley, J. Thomas, S. Kanangat, and M. L. Mucenski. 1995. Lymphotoxin-alpha-deficient mice. Effects on secondary lymphoid organ development and humoral immune responsiveness. J. Immunol. 155: 1685-1693.
37. De Togni, P., J. Goellner, N. H. Ruddle, P. R. Streeter, A. Fick, S. Mariathasan, S. C. Smith, R. Carlson, L. P. Shornick, J. Strauss-Schoenberger, et al 1994. Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin. Science 264: 703-707.
38. Fütterer, A., K. Mink, A. Luz, M. H. Kosco-Vilbois, and K. Pfeffer. 1998. The lymphotoxin beta receptor controls organogenesis and affinity maturation in peripheral lymphoid tissues. Immunity 9: 59-70.
39. Koni, P. A., R. Sacca, P. Lawton, J. L. Browning, N. H. Ruddle, and R. A. Flavell. 1997. Distinct roles in lymphoid organogenesis for lymphotoxins alpha and beta revealed in lymphotoxin beta-deficient mice. Immunity 6: 491-500.
40. Rennert, P. D., J. L. Browning, R. Mebius, F. Mackay, and P. S. Hochman. 1996. Surface lymphotoxin alpha/beta complex is required for the development of peripheral lymphoid organs. J. Exp. Med. 184: 1999-2006.
41. -CD4+ T cells from patients with the lymphocytic variant of hypereosinophilic syndrome reveals targeting of growth control pathways. Blood 114: 2969-2983.
42. Roufosse, F., L. Schandené, C. Sibille, B. Kennes, A. Efira, E. Cogan, and M. Goldman. 1999. T-cell receptor-independent activation of clonal Th2 cells associated with chronic hypereosinophilia. Blood 94: 994-1002.
43. Lantelme, E., S. Mantovani, B. Palermo, R. Campanelli, L. Granziero, V. Monafo, and C. Giachino. 2000. Increased frequency of RAG-expressing, CD4(+)CD3(low) peripheral T lymphocytes in patients with defective responses to DNA damage. Eur. J. Immunol. 30: 1520-1525.
44. Lantelme, E., B. Palermo, L. Granziero, S. Mantovani, R. Campanelli, V. Monafo, A. Lanzavecchia, and C. Giachino. 2000. Cutting edge: recombinase-activating gene expression and V(D)J recombination in CD4+CD3 low mature T lymphocytes. J. Immunol. 164: 3455-3459.
45. Tracey, D., L. Klareskog, E. H. Sasso, J. G. Salfeld, and P. P. Tak. 2008. Tumor necrosis factor antagonist mechanisms of action: a comprehensive review. Pharmacol. Ther. 117: 244-279.
46. Bikker, A., C. E. Hack, F. P. Lafeber, and J. A. van Roon. 2012. Interleukin-7: a key mediator in T cell-driven autoimmunity, inflammation, and tissue destruction. Curr. Pharm. Des. 18: 2347-2356.
47. Hartgring, S. A., J. W. Bijlsma, F. P. Lafeber, and J. A. van Roon. 2006. Interleukin-7 induced immunopathology in arthritis. Ann. Rheum. Dis. 65(Suppl. 3): iii69-iii74.
48. Hartgring, S. A., C. R. Willis, D. Alcorn, L. J. Nelson, J. W. Bijlsma, F. P. Lafeber, and J. A. van Roon. 2010. Blockade of the interleukin-7 receptor inhibits collagen-induced arthritis and is associated with reduction of T cell activity and proinflammatory mediators. Arthritis Rheum. 62: 2716-2725.
49. Hartgring, S. A., J. A. van Roon, M. Wenting-van Wijk, K. M. Jacobs, Z. N. Jahangier, C. R. Willis, J. W. Bijlsma, and F. P. Lafeber. 2009. Elevated expression of interleukin-7 receptor in inflamed joints mediates interleukin7-induced immune activation in rheumatoid arthritis. Arthritis Rheum. 60: 2595-2605.
50. Mebius, R. E. 2003. Organogenesis of lymphoid tissues. Nat. Rev. Immunol. 3: 292-303.